Pre-earnings options volume in Assertio Therapeutics is 1.8x normal with calls leading puts 13:2. Implied volatility suggests the market is anticipating a move near 29.1%, or 28c, after results are released. Median move over the past eight quarters is 10.4%.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks